{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T16:45:09Z","timestamp":1793810709450,"version":"4.6.1"},"reference-count":100,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.beem.2021.101595","type":"journal-article","created":{"date-parts":[[2021,10,13]],"date-time":"2021-10-13T03:56:41Z","timestamp":1634097401000},"page":"101595","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["The role of hormone therapy in urogenital health after menopause"],"prefix":"10.1016","volume":"35","author":[{"given":"Rossella E.","family":"Nappi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Cucinella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellis","family":"Martini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Cassani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.beem.2021.101595_bib1","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3109\/13697137.2012.657589","article-title":"The use of hormone therapy for the maintenance of urogynecological and sexual health post WHI","volume":"15","author":"Nappi","year":"2012","journal-title":"Climacteric"},{"key":"10.1016\/j.beem.2021.101595_bib2","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.maturitas.2009.03.012","article-title":"The effects of oestrogen on urogenital health","volume":"63","author":"Lachowsky","year":"2009","journal-title":"Maturitas"},{"key":"10.1016\/j.beem.2021.101595_bib3","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1097\/GME.0000000000001138","article-title":"The role of androgens in the treatment of genitourinary syndrome of menopause (GSM): international Society for the Study of Women's Sexual Health (ISSWSH) expert consensus panel review","volume":"25","author":"Simon","year":"2018","journal-title":"Menopause"},{"key":"10.1016\/j.beem.2021.101595_bib4","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.ogc.2018.07.010","article-title":"Genitourinary changes with aging","volume":"45","author":"Mitchell","year":"2018","journal-title":"Obstet Gynecol Clin N Am"},{"key":"10.1016\/j.beem.2021.101595_bib5","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1097\/GME.0000000000000329","article-title":"Vulvovaginal atrophy terminology consensus conference panel. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the international society for the study of women's sexual health and the North American menopause society","volume":"21","author":"Portman","year":"2014","journal-title":"Menopause"},{"key":"10.1016\/j.beem.2021.101595_bib6","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.ajog.2016.07.045","article-title":"Genitourinary syndrome of menopause: an overview of clinical manifestations, pathophysiology, etiology, evaluation, and management","volume":"215","author":"Gandhi","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.beem.2021.101595_bib7","doi-asserted-by":"crossref","first-page":"561","DOI":"10.3389\/fendo.2019.00561","article-title":"Addressing vulvovaginal atrophy (VVA)\/Genitourinary syndrome of menopause (GSM) for healthy aging in women","volume":"10","author":"Nappi","year":"2019","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.beem.2021.101595_bib8","doi-asserted-by":"crossref","first-page":"437","DOI":"10.2147\/IJWH.S44579","article-title":"Impact of vulvovaginal health on postmenopausal women: a review of surveys on symptoms of vulvovaginal atrophy","volume":"5","author":"Parish","year":"2013","journal-title":"Int J Wom Health"},{"key":"10.1016\/j.beem.2021.101595_bib9","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/GME.0000000000001728","article-title":"The genitourinary syndrome of menopause","volume":"28","author":"Phillips","year":"2021","journal-title":"Menopause"},{"issue":"28","key":"10.1016\/j.beem.2021.101595_bib10","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1097\/GME.0000000000001752","article-title":"Genitourinary syndrome of menopause: a systematic review on prevalence and treatment","volume":"15","author":"Mili","year":"2021","journal-title":"Menopause"},{"key":"10.1016\/j.beem.2021.101595_bib11","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3109\/13697137.2011.647840","article-title":"Vaginal health: Insights, views & attitudes (VIVA) - results from an international survey","volume":"15","author":"Nappi","year":"2012","journal-title":"Climacteric"},{"key":"10.1016\/j.beem.2021.101595_bib12","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1080\/13697137.2018.1446930","article-title":"The European Vulvovaginal Epidemiological Survey (EVES): prevalence, symptoms and impact of vulvovaginal atrophy of menopause","volume":"21","author":"Palacios","year":"2018","journal-title":"Climacteric"},{"key":"10.1016\/j.beem.2021.101595_bib13","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/GME.0000000000001260","article-title":"The burden of vulvovaginal atrophy on women's daily living: implications on quality of life from a face-to-face real-life survey","volume":"26","author":"Nappi","year":"2019","journal-title":"Menopause"},{"key":"10.1016\/j.beem.2021.101595_bib14","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.maturitas.2016.09.013","article-title":"Female sexual dysfunction (FSD): prevalence and impact on quality of life (QoL)","volume":"94","author":"Nappi","year":"2016","journal-title":"Maturitas"},{"key":"10.1016\/j.beem.2021.101595_bib15","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1097\/gme.0b013e31815a5168","article-title":"Vulvovaginal atrophy is strongly associated with female sexual dysfunction among sexually active postmenopausal women","volume":"15","author":"Levine","year":"2008","journal-title":"Menopause"},{"key":"10.1016\/j.beem.2021.101595_bib16","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.maturitas.2017.03.315","article-title":"Relationship between changes in vulvar-vaginal atrophy and changes in sexual functioning","volume":"100","author":"Pinkerton","year":"2017","journal-title":"Maturitas"},{"key":"10.1016\/j.beem.2021.101595_bib17","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/GME.0000000000001496","article-title":"The European Vulvovaginal Epidemiological Survey (EVES): impact on sexual function of vulvovaginal atrophy of menopause","volume":"27","author":"Particco","year":"2020","journal-title":"Menopause"},{"key":"10.1016\/j.beem.2021.101595_bib18","doi-asserted-by":"crossref","first-page":"252","DOI":"10.3109\/13697137.2016.1173026","article-title":"The American-European difference in vulvar and vaginal atrophy views: a lesson from the REVIVE Survey","volume":"19","author":"Nappi","year":"2016","journal-title":"Climacteric"},{"key":"10.1016\/j.beem.2021.101595_bib19","first-page":"2232","article-title":"The CLOSER (CLarifying Vaginal Atrophy's Impact on SEx and Relationships) survey: implications of vaginal discomfort in postmenopausal women and in male partners","volume":"10","author":"Nappi","year":"2013","journal-title":"J\u00a0Sex Med"},{"key":"10.1016\/j.beem.2021.101595_bib20","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.maturitas.2013.05.003","article-title":"The CLOSER survey: impact of postmenopausal vaginal discomfort on relationships between women and their partners in Northern and Southern Europe","volume":"75","author":"Nappi","year":"2013","journal-title":"Maturitas"},{"key":"10.1016\/j.beem.2021.101595_bib21","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/GME.0000000000001275","article-title":"Women's experience of vulvovaginal symptoms associated with menopause","volume":"26","author":"Shifren","year":"2019","journal-title":"Menopause"},{"key":"10.1016\/j.beem.2021.101595_bib22","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1089\/jwh.2014.5177","article-title":"The association between vulvovaginal atrophy symptoms and quality of life among postmenopausal women in the United States and Western Europe","volume":"24","author":"DiBonaventura","year":"2015","journal-title":"J\u00a0Wom Health"},{"key":"10.1016\/j.beem.2021.101595_bib23","first-page":"413","article-title":"The women's EMPOWER survey: identifying women's perceptions on vulvar and vaginal atrophy and its treatment","volume":"14","author":"Kingsberg","year":"2017","journal-title":"J\u00a0Sex Med"},{"key":"10.1016\/j.beem.2021.101595_bib24","first-page":"425","article-title":"The women's EMPOWER survey: women's knowledge and awareness of treatment options for vulvar and vaginal atrophy remains inadequate","volume":"14","author":"Krychman","year":"2017","journal-title":"J\u00a0Sex Med"},{"key":"10.1016\/j.beem.2021.101595_bib25","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1517\/14656566.2015.1020791","article-title":"Advances in pharmacotherapy for treating female sexual dysfunction","volume":"16","author":"Nappi","year":"2015","journal-title":"Expet Opin Pharmacother"},{"key":"10.1016\/j.beem.2021.101595_bib26","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.maturitas.2019.03.013","article-title":"Symptom severity and quality of life in the management of vulvovaginal atrophy in postmenopausal women","volume":"124","author":"Panay","year":"2019","journal-title":"Maturitas"},{"key":"10.1016\/j.beem.2021.101595_bib27","first-page":"603","article-title":"The use of estrogen therapy in women's sexual functioning (CME)","volume":"6","author":"Nappi","year":"2009","journal-title":"J\u00a0Sex Med"},{"key":"10.1016\/j.beem.2021.101595_bib28","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.sxmr.2018.03.005","article-title":"Role of androgens in female genitourinary tissue structure and function: implications in the genitourinary syndrome of menopause","volume":"6","author":"Traish","year":"2018","journal-title":"Sex Med Rev"},{"key":"10.1016\/j.beem.2021.101595_bib29","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1097\/GME.0000000000001587","article-title":"Expression of androgen receptors in the structures of vulvovaginal tissue","volume":"27","author":"Palacios","year":"2020","journal-title":"Menopause"},{"key":"10.1016\/j.beem.2021.101595_bib30","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1097\/GME.0000000000000808","article-title":"Science of intracrinology in postmenopausal women","volume":"24","author":"Labrie","year":"2017","journal-title":"Menopause"},{"key":"10.1016\/j.beem.2021.101595_bib31","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/GME.0000000000001177","article-title":"Intracrinology and menopause: the science describing the cell-specific intracellular formation of estrogens and androgens from DHEA and their strictly local action and inactivation in peripheral tissues","volume":"26","author":"Labrie","year":"2019","journal-title":"Menopause"},{"key":"10.1016\/j.beem.2021.101595_bib32","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/GME.0000000000001644","article-title":"The effect of pathophysiological changes in the vaginal milieu on the signs and symptoms of genitourinary syndrome of menopause (GSM)","volume":"28","author":"Qi","year":"2020","journal-title":"Menopause"},{"issue":"Suppl 1","key":"10.1016\/j.beem.2021.101595_bib33","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3109\/13697137.2015.1078206","article-title":"The urogenital system and the menopause","volume":"18","author":"Calleja-Agius","year":"2015","journal-title":"Climacteric"},{"issue":"Suppl 1","key":"10.1016\/j.beem.2021.101595_bib34","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0090-4295(03)00676-9","article-title":"The role of estrogens in female lower urinary tract dysfunction","volume":"62","author":"Robinson","year":"2003","journal-title":"Urology"},{"key":"10.1016\/j.beem.2021.101595_bib35","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.maturitas.2020.06.018","article-title":"Viewing symptoms associated with Vulvovaginal Atrophy (VVA)\/Genitourinary syndrome of menopause (GSM) through the estro-androgenic lens - cluster analysis of a web-based Italian survey among women over 40","volume":"140","author":"Nappi","year":"2020","journal-title":"Maturitas"},{"key":"10.1016\/j.beem.2021.101595_bib36","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1080\/13697137.2018.1482647","article-title":"Sexual well-being after menopause: an international menopause society white paper","volume":"21","author":"Simon","year":"2018","journal-title":"Climacteric"},{"key":"10.1016\/j.beem.2021.101595_bib37","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.maturitas.2015.09.001","article-title":"Vaginal atrophy of women in postmenopause. Results from a multicentric observational study: the AGATA study","volume":"83","author":"Palma","year":"2016","journal-title":"Maturitas"},{"issue":"Suppl 2","key":"10.1016\/j.beem.2021.101595_bib38","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1080\/13697130701599876","article-title":"New attitudes to sexuality in the menopause: clinical evaluation and diagnosis","volume":"10","author":"Nappi","year":"2007","journal-title":"Climacteric"},{"key":"10.1016\/j.beem.2021.101595_bib39","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1097\/GME.0000000000001609","article-title":"The 2020 genitourinary syndrome of menopause position statement of the North American Menopause Society","volume":"27","year":"2020","journal-title":"Menopause"},{"key":"10.1016\/j.beem.2021.101595_bib40","doi-asserted-by":"crossref","first-page":"509","DOI":"10.3109\/13697137.2010.522875","article-title":"Recommendations for the management of postmenopausal vaginal atrophy","volume":"13","author":"Sturdee","year":"2010","journal-title":"Climacteric"},{"key":"10.1016\/j.beem.2021.101595_bib41","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/GME.0000000000001714","article-title":"Genitourinary syndrome of menopause and age: a new algorithm for hormonal treatment?","volume":"28","author":"Phillips","year":"2020","journal-title":"Menopause"},{"key":"10.1016\/j.beem.2021.101595_bib42","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/GME.0000000000001666","article-title":"Does age at the start of treatment for vaginal atrophy predict response to vaginal estrogen therapy? Post hoc analysis of data from a randomized clinical trial involving 205 women treated with 10\u03bcgestradiol vaginal tablets","volume":"28","author":"Derzko","year":"2020","journal-title":"Menopause"},{"key":"10.1016\/j.beem.2021.101595_bib43","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3109\/13697137.2015.1129166","article-title":"2016 IMS Recommendations on women's midlife health and menopause hormone therapy","volume":"19","author":"Baber","year":"2016","journal-title":"Climacteric"},{"key":"10.1016\/j.beem.2021.101595_bib44","first-page":"1463","article-title":"Female sexual dysfunction-medical and psychological treatments, committee 14","volume":"14","author":"Kingsberg","year":"2017","journal-title":"J\u00a0Sex Med"},{"key":"10.1016\/j.beem.2021.101595_bib45","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3109\/13697130903437615","article-title":"Therapeutic options for postmenopausal female sexual dysfunction","volume":"13","author":"Al-Azzawi","year":"2010","journal-title":"Climacteric"},{"key":"10.1016\/j.beem.2021.101595_bib46","first-page":"1567","article-title":"Resistance and barriers to local estrogen therapy in women with atrophic vaginitis","volume":"10","author":"Kingsberg","year":"2013","journal-title":"J\u00a0Sex Med"},{"key":"10.1016\/j.beem.2021.101595_bib47","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.maturitas.2016.06.010","article-title":"The REVIVE (REal Women's VIews of Treatment Options for Menopausal Vaginal ChangEs) survey in Europe: country-specific comparisons of postmenopausal women's perceptions, experiences and needs","volume":"91","author":"Nappi","year":"2016","journal-title":"Maturitas"},{"key":"10.1016\/j.beem.2021.101595_bib48","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.maturitas.2015.07.020","article-title":"Update on management of genitourinary syndrome of menopause: a practical guide","volume":"82","author":"Palacios","year":"2015","journal-title":"Maturitas"},{"key":"10.1016\/j.beem.2021.101595_bib49","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1080\/14656566.2019.1574752","article-title":"Pharmacotherapy for the treatment of vaginal atrophy","volume":"20","author":"Donders","year":"2019","journal-title":"Expet Opin Pharmacother"},{"key":"10.1016\/j.beem.2021.101595_bib50","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1097\/GME.0000000000001052","article-title":"A\u00a0systematic review of intravaginal testosterone for the treatment of vulvovaginal atrophy","volume":"25","author":"Bell","year":"2018","journal-title":"Menopause"},{"key":"10.1016\/j.beem.2021.101595_bib51","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/ijgo.13561","article-title":"Physical methods for the treatment of genitourinary syndrome of menopause: a systematic review","volume":"153","author":"Sarmento","year":"2021","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.beem.2021.101595_bib52","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.maturitas.2019.03.002","article-title":"Pelvic floor muscle training as a treatment for genitourinary syndrome of menopause: a single-arm feasibility study","volume":"125","author":"Mercier","year":"2019","journal-title":"Maturitas"},{"issue":"Suppl 1","key":"10.1016\/j.beem.2021.101595_bib53","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3109\/13697137.2015.1079100","article-title":"Treatment of the genitourinary syndrome of menopause","volume":"18","author":"Palacios","year":"2015","journal-title":"Climacteric"},{"key":"10.1016\/j.beem.2021.101595_bib54","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/13697137.2020.1820478","article-title":"Vaginal lubricants and moisturizers: a review into use, efficacy, and safety","volume":"24","author":"Potter","year":"2021","journal-title":"Climacteric"},{"key":"10.1016\/j.beem.2021.101595_bib55","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.maturitas.2021.04.005","article-title":"Topical estrogens and non-hormonal preparations for postmenopausal vulvovaginal atrophy: an EMAS clinical guide","volume":"148","author":"Hirschberg","year":"2021","journal-title":"Maturitas"},{"issue":"5 Pt 1","key":"10.1016\/j.beem.2021.101595_bib56","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1097\/01.AOG.0000158120.47542.18","article-title":"Menopausal symptoms and treatment-related effects of estrogen and progestin in the Women's Health Initiative","volume":"105","author":"Barnabei","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.beem.2021.101595_bib57","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.maturitas.2012.06.009","article-title":"EMAS clinical guide: low-dose vaginal estrogens for postmenopausal vaginal atrophy","volume":"73","author":"Rees","year":"2012","journal-title":"Maturitas"},{"key":"10.1016\/j.beem.2021.101595_bib58","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1080\/13697137.2017.1329291","article-title":"The efficacy and safety of estriol to treat vulvovaginal atrophy in postmenopausal women: a systematic literature review","volume":"20","author":"Rueda","year":"2017","journal-title":"Climacteric"},{"key":"10.1016\/j.beem.2021.101595_bib59","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1080\/13697137.2017.1421923","article-title":"Treatment of vaginal atrophy with estriol and lactobacilli combination: a clinical review","volume":"21","author":"Mueck","year":"2018","journal-title":"Climacteric"},{"key":"10.1016\/j.beem.2021.101595_bib60","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/GME.0000000000001468","article-title":"Safety of vaginal estrogens: a systematic review","volume":"27","author":"Crandall","year":"2020","journal-title":"Menopause"},{"key":"10.1016\/j.beem.2021.101595_bib61","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1097\/GME.0000000000001315","article-title":"Endometrial safety of low-dose vaginal estrogens in menopausal women: a systematic evidence review","volume":"26","author":"Constantine","year":"2019","journal-title":"Menopause"},{"key":"10.1016\/j.beem.2021.101595_bib62","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/GME.0000000000000956","article-title":"Breast cancer, endometrial cancer, and cardiovascular events in participants who used vaginal estrogen in the Women's Health Initiative Observational Study","volume":"25","author":"Crandall","year":"2018","journal-title":"Menopause"},{"key":"10.1016\/j.beem.2021.101595_bib63","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1097\/GME.0000000000001284","article-title":"Vaginal estrogen use and chronic disease risk in the Nurses' Health Study","volume":"26","author":"Bhupathiraju","year":"2018","journal-title":"Menopause"},{"key":"10.1016\/j.beem.2021.101595_bib64","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1097\/GME.0000000000000316","article-title":"Why the product labeling for low-dose vaginal estrogen should be changed","volume":"21","author":"Manson","year":"2014","journal-title":"Menopause"},{"key":"10.1016\/j.beem.2021.101595_bib65","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/GME.0000000000001463","article-title":"Systemic estradiol levels with low-dose vaginal estrogens","volume":"27","author":"Santen","year":"2020","journal-title":"Menopause"},{"key":"10.1016\/j.beem.2021.101595_bib66","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3109\/13697137.2015.1098609","article-title":"Pharmacokinetics and preliminary efficacy of two vaginal gel formulations of ultra-low-dose estriol in postmenopausal women","volume":"19","author":"Delgado","year":"2016","journal-title":"Climacteric"},{"key":"10.1016\/j.beem.2021.101595_bib67","doi-asserted-by":"crossref","first-page":"644","DOI":"10.3109\/09513591003767948","article-title":"Urogenital disorders associated with oestrogen deficiency: the role of promestriene as topical oestrogen therapy","volume":"26","author":"Santos","year":"2010","journal-title":"Gynecol Endocrinol"},{"issue":"8","key":"10.1016\/j.beem.2021.101595_bib68","first-page":"CD001500","article-title":"Local oestrogen for vaginal atrophy in postmenopausal women","volume":"2016","author":"Lethaby","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.beem.2021.101595_bib69","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.maturitas.2003.11.009","article-title":"Are all estrogens the same?","volume":"47","author":"Coelingh Bennink","year":"2004","journal-title":"Maturitas"},{"key":"10.1016\/j.beem.2021.101595_bib70","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1097\/GME.0000000000001131","article-title":"Effects of vaginal estradiol tablets and moisturizer on menopause-specific quality of life and mood in healthy postmenopausal women with vaginal symptoms: a randomized clinical trial","volume":"25","author":"Diem","year":"2018","journal-title":"Menopause"},{"key":"10.1016\/j.beem.2021.101595_bib71","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1097\/GME.0000000000001341","article-title":"Sexual frequency and pain in a randomized clinical trial of vaginal estradiol tablets, moisturizer, and placebo in postmenopausal women","volume":"26","author":"Mitchell","year":"2019","journal-title":"Menopause"},{"key":"10.1016\/j.beem.2021.101595_bib72","first-page":"1","article-title":"Sustainability of vaginal estrogens for genitourinary syndrome of menopause - a systematic review","author":"Weidlinger","year":"2021","journal-title":"Climacteric"},{"key":"10.1016\/j.beem.2021.101595_bib73","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/GME.0000000000001221","article-title":"A\u00a0systematic review of the efficacy and safety of vaginal estrogen products for the treatment of genitourinary syndrome of menopause","volume":"26","author":"Biehl","year":"2019","journal-title":"Menopause"},{"key":"10.1016\/j.beem.2021.101595_bib74","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.urology.2020.05.058","article-title":"Effective prevention of recurrent UTIs with vaginal estrogen: pearls for a urological approach to genitourinary syndrome of menopause","volume":"151","author":"Buck","year":"2021","journal-title":"Urology"},{"key":"10.1016\/j.beem.2021.101595_bib75","first-page":"282","article-title":"Recurrent uncomplicated urinary tract infections in women: AUA\/CUA\/SUFU guideline","volume":"202","author":"Anger","year":"2019","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.beem.2021.101595_bib76","article-title":"Oestrogen therapy for urinary incontinence in post-menopausal women","volume":"10","author":"Cody","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.beem.2021.101595_bib77","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.maturitas.2020.09.005","article-title":"Management of urinary incontinence in postmenopausal women: an EMAS clinical guide","volume":"143","author":"Russo","year":"2021","journal-title":"Maturitas"},{"key":"10.1016\/j.beem.2021.101595_bib78","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1080\/14656566.2019.1703951","article-title":"An overview of dehydroepiandrosterone (EM-760) as a treatment option for genitourinary syndrome of menopause","volume":"21","author":"Holton","year":"2020","journal-title":"Expet Opin Pharmacother"},{"key":"10.1016\/j.beem.2021.101595_bib79","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1097\/GME.0000000000000910","article-title":"Combined data of intravaginal prasterone against vulvovaginal atrophy of menopause","volume":"24","author":"Labrie","year":"2017","journal-title":"Menopause"},{"key":"10.1016\/j.beem.2021.101595_bib80","first-page":"2401","article-title":"Effect of intravaginal prasterone on sexual dysfunction in postmenopausal women with vulvovaginal atrophy","volume":"12","author":"Labrie","year":"2015","journal-title":"J\u00a0Sex Med"},{"key":"10.1016\/j.beem.2021.101595_bib81","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1097\/GME.0000000000000470","article-title":"Lack of effect of intravaginal dehydroepiandrosterone (DHEA, prasterone) on the endometrium in postmenopausal women","volume":"22","author":"Portman","year":"2015","journal-title":"Menopause"},{"key":"10.1016\/j.beem.2021.101595_bib82","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1080\/17446651.2019.1657008","article-title":"Ospemifene for the treatment of menopausal vaginal dryness, a symptom of the genitourinary syndrome of menopause","volume":"14","author":"Archer","year":"2019","journal-title":"Expet Rev Endocrinol Metabol"},{"key":"10.1016\/j.beem.2021.101595_bib83","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.maturitas.2018.11.016","article-title":"Ospemifene for the treatment of vulvar and vaginal atrophy: a meta-analysis of randomized trials. Part I: evaluation of efficacy","volume":"121","author":"Di Donato","year":"2019","journal-title":"Maturitas"},{"key":"10.1016\/j.beem.2021.101595_bib84","doi-asserted-by":"crossref","first-page":"226","DOI":"10.3109\/13697137.2014.954996","article-title":"Female sexual function improved with ospemifene in postmenopausal women with vulvar and vaginal atrophy: results of a randomized, placebo-controlled trial","volume":"18","author":"Constantine","year":"2015","journal-title":"Climacteric"},{"key":"10.1016\/j.beem.2021.101595_bib85","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1080\/13697137.2017.1284780","article-title":"Systematic indirect comparison of ospemifene versus local estrogens for vulvar and vaginal atrophy","volume":"20","author":"Bruyniks","year":"2017","journal-title":"Climacteric"},{"key":"10.1016\/j.beem.2021.101595_bib86","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.maturitas.2020.05.001","article-title":"Potential effectiveness of Ospemifene on Detrusor Overactivity in patients with vaginal atrophy","volume":"138","author":"Novara","year":"2020","journal-title":"Maturitas"},{"key":"10.1016\/j.beem.2021.101595_bib87","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.maturitas.2018.11.017","article-title":"Ospemifene for the treatment of vulvar and vaginal atrophy: a meta-analysis of randomized trials. Part II: evaluation of tolerability and safety","volume":"121","author":"Di Donato","year":"2019","journal-title":"Maturitas"},{"key":"10.1016\/j.beem.2021.101595_bib88","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.maturitas.2020.06.021","article-title":"No increase in incidence or risk of recurrence of breast cancer in ospemifene-treated patients with vulvovaginal atrophy (VVA)","volume":"142","author":"Cai","year":"2020","journal-title":"Maturitas"},{"key":"10.1016\/j.beem.2021.101595_bib89","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1097\/GME.0000000000001552","article-title":"Incidence of venous thromboembolism among postmenopausal women prescribed ospemifene, selective estrogen receptor modulators for noncancer indications, or untreated vulvar and vaginal atrophy","volume":"27","author":"Nordstrom","year":"2020","journal-title":"Menopause"},{"key":"10.1016\/j.beem.2021.101595_bib90","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1080\/13697137.2019.1575356","article-title":"Sexuality in premature ovarian insufficiency","volume":"22","author":"Nappi","year":"2019","journal-title":"Climacteric"},{"key":"10.1016\/j.beem.2021.101595_bib91","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1080\/13697137.2020.1804547","article-title":"Premature ovarian insufficiency: an international menopause society white paper","volume":"23","author":"Panay","year":"2020","journal-title":"Climacteric"},{"key":"10.1016\/j.beem.2021.101595_bib92","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1097\/AOG.0000000000003729","article-title":"Clinical effects of early or surgical menopause","volume":"135","author":"Kingsberg","year":"2020","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.beem.2021.101595_bib93","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1200\/JCO.2017.75.8995","article-title":"Interventions to address sexual problems in people with cancer: American society of clinical Oncology clinical practice guideline adaptation of cancer care ontario guideline","volume":"36","author":"Carter","year":"2018","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.beem.2021.101595_bib94","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ajog.2019.08.043","article-title":"Management of genitourinary syndrome of menopause in female cancer patients: a focus on vaginal hormonal therapy","volume":"222","author":"Crean-Tate","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.beem.2021.101595_bib95","doi-asserted-by":"crossref","first-page":"3647","DOI":"10.1210\/jc.2017-01138","article-title":"Managing menopausal symptoms and associated clinical issues in breast cancer survivors","volume":"102","author":"Santen","year":"2017","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"key":"10.1016\/j.beem.2021.101595_bib96","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1097\/GME.0000000000001121","article-title":"Management of genitourinary syndrome of menopause in women with or at high risk for breast cancer: consensus recommendations from the North American Menopause Society and the International Society for the Study of Women's Sexual Health","volume":"25","author":"Faubion","year":"2018","journal-title":"Menopause"},{"key":"10.1016\/j.beem.2021.101595_bib97","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.maturitas.2020.08.010","article-title":"Genitourinary syndrome of menopause: current treatment options in breast cancer survivors - systematic review","volume":"143","author":"Mension","year":"2021","journal-title":"Maturitas"},{"key":"10.1016\/j.beem.2021.101595_bib98","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1080\/13697137.2019.1643180","article-title":"Vulvovaginal atrophy in women after cancer","volume":"22","author":"Cox","year":"2019","journal-title":"Climacteric"},{"key":"10.1016\/j.beem.2021.101595_bib99","doi-asserted-by":"crossref","first-page":"4146","DOI":"10.1210\/jc.2018-01345","article-title":"Intravaginal testosterone improves sexual satisfaction and vaginal symptoms associated with aromatase inhibitors","volume":"103","author":"Davis","year":"2018","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"key":"10.1016\/j.beem.2021.101595_bib100","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.clbc.2015.06.005","article-title":"Genitourinary syndrome of menopause in breast cancer survivors: are we facing new and safe hopes?","volume":"15","author":"Biglia","year":"2015","journal-title":"Clin Breast Cancer"}],"container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X21001123?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X21001123?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:57:04Z","timestamp":1761497824000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X21001123"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":100,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S1521690X21001123"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2021.101595","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of hormone therapy in urogenital health after menopause","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2021.101595","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101595"}}